Navigation Links
NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients
Date:7/22/2008

naproxen 250 mg bid, naproxen 500 mg bid or ibuprofen 600 mg tid (three times daily).

The data from the 111 and 112 studies will complement the results of a 2-week ABPM study with naproxcinod compared to naproxen in hypertensive volunteers (the 104 study), which were presented at the American Heart Association (AHA) in November 2007. They will also complement the Office Blood Pressure Measurements (OBPMs) being collected in each of the pivotal phase 3 OA studies (including the completed 301 study and the ongoing 302 and 303 studies).

Maarten Beekman, Vice President of Clinical Development and Medical Affairs at NicOx commented: "We are very pleased to have fully enrolled these two clinical pharmacology studies and we look forward to their results in the fourth quarter of this year. We believe the timely achievement of this milestone is a testament to the strength of the clinical team we have assembled at NicOx and also reflects the interest of clinical centers and patients in naproxcinod."

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational drugs for unmet medical needs. NicOx is applying its proprietary nitric oxide-donating technology to develop an internal portfolio of New Chemical Entities (NCEs) in the therapeutic areas of inflammatory and cardio-metabolic disease.

Resources are focused on the development of naproxcinod, a proprietary NCE and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in 2008.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-donating NCEs, which are in development internally and with partners, including Pfizer Inc and Merck & Co., Inc., for the treatment of prevalen
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. NicOx Naproxcinod ABPM Data Presented at American Heart Association
4. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
5. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
6. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
7. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
8. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
9. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
10. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
11. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...v. 20 Reportlinker.com announces t...ts catalogue. ,, Blood Pressure Monitoring &am...is ,, http://www.reportlinker.com/p0164309/B...--A-World-Market-Analysis.html#utm_source=prnewswi... ,, Measurement of blood pressure is not only a...
(Date:11/20/2009)...v. 20 Reportlinker.com announces t...ts catalogue. ,, Pipettes & Pipettors - A ...rtlinker.com/p0164373/Pipettes--Pipettors---A-Glob...mp;utm_medium=pr&utm_campaign=prnewswire ,...al part of any research laboratory. Large-scale ap...
(Date:11/20/2009)...v. 20 ,, Reportlinker.com annou...e in its catalogue. ,, Global Markets for Brea...inker.com/p0164741/Global-Markets-for-Breast-Biops...medium=pr&utm_campaign=prnewswire ,, The ...the spring loaded core needle market and vacuum as...
Breaking Medicine Technology:Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Heritage Provider Network and Dr Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 57866 1Heritage Provider Network and Dr Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 57866 2Alzheimers Foundation of America Names Actor Hector Elizondo as Honorary Chairman 57864 1Alzheimers Foundation of America Names Actor Hector Elizondo as Honorary Chairman 57864 2InfoLogix Receives Nasdaq Deficiency Letter 57862 1InfoLogix Receives Nasdaq Deficiency Letter 57862 2InfoLogix Receives Nasdaq Deficiency Letter 57862 3
(Date:11/22/2009)..., DALLAS Nov. 23, 2009 UT Southwestern Medical C...ional Institutes of Health to share $56 million ov...sortium (ICAC). , The ICAC, which receives fund...y and Infectious Diseases, investigates novel trea...Dr. Rebecca Gruchalla, chief of allergy and immuno...
(Date:11/22/2009)...On the skin,s surface, bacteria are abundant, dive... Research at the University of California, San Di...acteria living on the skin surface trigger a pathw...ry. , "These germs are actually good for us," sa...e and pediatrics, chief of UCSD,s Division of Derm...
(Date:11/22/2009)... HealthSmart, an innovative...nced that it has successfully completed a recapita...ompany’s other lenders. Silver Point Capita...nwich, Connecticut. This recapitalization allows ...ts business strategy. , , ...
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewswi...e voted to proceed to Senator Reid,s version of th...veral objectionable items included in this bill; l...dates, is the government funding for elective abor...ionable. Additionally the bill provides subsidies ...
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewsw...s to eliminate onchocerciasis (river blindness) in...ence of the disease in recent years, as evidenced ...uiring mass drug administration in six endemic cou...nnual meeting of the American Society of Tropical ...
Breaking Medicine News(10 mins):Health News:UT Southwestern receives continued NIH funding for Inner City Asthma Consortium 2Health News:Surface bacteria maintain skin's healthy balance 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4
...gest soft drink brand and food giant-Coco Cola and...ink called Enviga, endowed with extracts of natura...This is expected to hit the market next month in A...ries burnt. The soft drink company claims that det...
...der a new proposal released by Gov. Arnold Schwarz...joy health insurance with a double benefit - to th...ed to pay health premiums which will be exempted f...who are unable to afford the coverage presently. W...
...ic waste may make you diabetic, says a study that ...ork between 1993 and 2000.// Type-two diabet... to 13.3 million Americans from 1980 to 2002. Whil... by Lawrence Lessner and colleagues at the Univers...
...n will come to effect from Jan. 5, 2007,that is de...itals in California. This regulation will help// ... care. Otherwise, pharmacists are more involved i...o check the work of other technicians, to help rul...
...ontrol Organization (NACO) of India plans to promo...in the battle against HIV/AIDS//. The third phase ...is likely to be launched in April. Statistics...ring committee, which comprises of the Confederati...
... over refusal of surgery to known smokers is all s...erts debating the issue in this week’s BMJ//. The ...are trust last year to remove smokers from the wai... is justified under specific situations. Smoking i...
Other Medicine News:Health News:Living Near Toxic Waste May Bring On Diabetes 2Health News:New Regulation to Check Medication Errors 2Health News:Refusal of Surgery for Smokers – To Be or Not to Be 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: